Skip to main navigation Skip to search Skip to main content

Corrigendum to “Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA” [Tuberculosis 107 (December 2017) 133–136] (S1472979217303074) (10.1016/j.tube.2017.09.003))

  • Matthew B. McNeil
  • , Devon Dennison
  • , Catherine Shelton
  • , Lindsay Flint
  • , Aaron Korkegian
  • , Tanya Parish
  • Infectious Disease Research Institute
  • TB Discovery Research

Research output: Contribution to journalComment/debate

Abstract

In the version of this article initially published the authors omitted a funding source. The correct funding paragraph is as follows. Research reported in this publication was supported in part by NIAID of the National Institutes of Health under award numbers R01AI09918 and R01AI125160, by the Bill and Melinda Gates Foundation, under grant OPP1024038 and by Anacor Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)123
Number of pages1
JournalTuberculosis
Volume110
Early online date21 Feb 2018
DOIs
Publication statusPublished - 17 May 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA” [Tuberculosis 107 (December 2017) 133–136] (S1472979217303074) (10.1016/j.tube.2017.09.003))'. Together they form a unique fingerprint.

Cite this